Robert W. Sauerwein
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 228 publications
Vaccine-induced mouse antibodies targeting Plasmodium falciparum PfVFT antigen inhibit blood stages through multiple mechanisms.
Journal: NPJ vaccines
Published: September 11, 2025
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Journal: eLife
Published: January 16, 2025
Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.
Journal: The Lancet. Microbe
Published: January 07, 2025
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Sporozoite immunization: innovative translational science to support the fight against malaria.
Journal: Expert review of vaccines
Published: August 12, 2023
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.
Journal: Cell reports
Published: July 23, 2023
The decrease in plasma cholesterol during Plasmodium falciparum infections is not caused by cholesterol utilization by the parasites but by an infection-induced acute-phase response.
Journal: The Journal of infection
Published: February 18, 2023
Baseline TGF-β correlates with protection after immunization with Plasmodium falciparum sporozoites in the controlled human malaria infection model.
Journal: Immunology letters
Published: February 13, 2023
Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening.
Journal: Communications biology
Published: October 12, 2022
Last Updated: 09/26/2026